世界卫生组织《2022年全球结核病报告》。 - Suppr

Suppr

超能文献

WHO's Global Tuberculosis Report 2022.

作者信息

Bagcchi Sanjeet

出版信息

Lancet Microbe. 2023 Jan;4(1):e20. doi: 10.1016/S2666-5247(22)00359-7. Epub 2022 Dec 12.

DOI:10.1016/S2666-5247(22)00359-7

PMID:36521512

Abstract

摘要

相似文献

WHO's Global Tuberculosis Report 2022.

Lancet Microbe. 2023 Jan;4(1):e20. doi: 10.1016/S2666-5247(22)00359-7. Epub 2022 Dec 12.

WHO's 2013 global report on tuberculosis: successes, threats, and opportunities.

Lancet. 2013 Nov 30;382(9907):1765-7. doi: 10.1016/S0140-6736(13)62078-4. Epub 2013 Oct 23.

WHO's who in tuberculosis.

Lancet Infect Dis. 2018 Feb;18(2):147. doi: 10.1016/S1473-3099(18)30005-7.

WHO's End TB Strategy: From stopping to ending the global TB epidemic.

Indian J Tuberc. 2015 Oct;62(4):196-9. doi: 10.1016/j.ijtb.2015.11.001. Epub 2016 Jan 23.

Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets: Worldwide, 2019.

Pediatr Infect Dis J. 2021 Aug 1;40(8):752. doi: 10.1097/INF.0000000000003241.

Management of Conflicts of Interest in WHO's Consultative Processes on Global Alcohol Policy.

Int J Health Policy Manag. 2022 Oct 19;11(10):2219-2227. doi: 10.34172/ijhpm.2021.139. Epub 2021 Oct 3.

WHO's special programmes: undermining from above.

BMJ. 1995 Jan 21;310(6973):178-82. doi: 10.1136/bmj.310.6973.178a.

Renewing the fight to end tuberculosis.

Lancet Public Health. 2021 May;6(5):e260. doi: 10.1016/S2468-2667(21)00068-2. Epub 2021 Mar 26.

Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets - Worldwide, 2019.

MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):427-430. doi: 10.15585/mmwr.mm7012a4.

Global Epidemiology of Tuberculosis and Progress Toward Achieving Global Targets - 2017.

MMWR Morb Mortal Wkly Rep. 2019 Mar 22;68(11):263-266. doi: 10.15585/mmwr.mm6811a3.

引用本文的文献

Miliary tuberculosis and central nervous system infection caused by hematogenous transmission from a primary subcutaneous tuberculous abscess: A case report.

Medicine (Baltimore). 2025 Sep 5;104(36):e44221. doi: 10.1097/MD.0000000000044221.

Isoniazid-rhodanine molecular hybrids: design, synthesis, antimycobacterial activity and computational validation.

RSC Adv. 2025 Sep 1;15(38):31272-31288. doi: 10.1039/d5ra03641k. eCollection 2025 Aug 29.

Risk factors and prevalence of latent tuberculosis infection in rheumatic patients: a meta-analysis.

BMC Infect Dis. 2025 Sep 2;25(1):1094. doi: 10.1186/s12879-025-11460-x.

Opportunistic use of artificial intelligence with X-ray imaging for diagnosis of HIV status in tuberculosis patients in Uganda and Tanzania.

PLOS Digit Health. 2025 Sep 2;4(9):e0000988. doi: 10.1371/journal.pdig.0000988. eCollection 2025 Sep.

Burden of tuberculosis in Eastern Africa region from 1990-2021: A systematic analysis for the Global Burden of Disease 2021 Study.

PLoS One. 2025 Sep 2;20(9):e0331035. doi: 10.1371/journal.pone.0331035. eCollection 2025.

Recent advancements in drug development for pulmonary tuberculosis.

Arch Microbiol. 2025 Aug 30;207(10):245. doi: 10.1007/s00203-025-04415-y.

Unlocking the secrets of glucose metabolism reprogramming: the role in pulmonary diseases.

Front Pharmacol. 2025 Aug 13;16:1551452. doi: 10.3389/fphar.2025.1551452. eCollection 2025.

Gut microbiota and tuberculosis.

Imeta. 2025 Jun 22;4(4):e70054. doi: 10.1002/imt2.70054. eCollection 2025 Aug.

Higher proportion of coagulative necrosis and PD-L1 immune cells in splenic tuberculosis.

Sci Rep. 2025 Aug 26;15(1):31348. doi: 10.1038/s41598-025-15754-7.

Whole-genome sequencing and machine learning reveal key drivers of delayed sputum conversion in rifampicin-resistant tuberculosis.

Front Cell Infect Microbiol. 2025 Aug 7;15:1641385. doi: 10.3389/fcimb.2025.1641385. eCollection 2025.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

WHO's Global Tuberculosis Report 2022.

Lancet Microbe. 2023 Jan;4(1):e20. doi: 10.1016/S2666-5247(22)00359-7. Epub 2022 Dec 12.

WHO's 2013 global report on tuberculosis: successes, threats, and opportunities.

Lancet. 2013 Nov 30;382(9907):1765-7. doi: 10.1016/S0140-6736(13)62078-4. Epub 2013 Oct 23.

WHO's who in tuberculosis.

Lancet Infect Dis. 2018 Feb;18(2):147. doi: 10.1016/S1473-3099(18)30005-7.

WHO's End TB Strategy: From stopping to ending the global TB epidemic.

Indian J Tuberc. 2015 Oct;62(4):196-9. doi: 10.1016/j.ijtb.2015.11.001. Epub 2016 Jan 23.

Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets: Worldwide, 2019.

Pediatr Infect Dis J. 2021 Aug 1;40(8):752. doi: 10.1097/INF.0000000000003241.

Management of Conflicts of Interest in WHO's Consultative Processes on Global Alcohol Policy.

Int J Health Policy Manag. 2022 Oct 19;11(10):2219-2227. doi: 10.34172/ijhpm.2021.139. Epub 2021 Oct 3.

WHO's special programmes: undermining from above.

BMJ. 1995 Jan 21;310(6973):178-82. doi: 10.1136/bmj.310.6973.178a.

Renewing the fight to end tuberculosis.

Lancet Public Health. 2021 May;6(5):e260. doi: 10.1016/S2468-2667(21)00068-2. Epub 2021 Mar 26.

Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets - Worldwide, 2019.

MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):427-430. doi: 10.15585/mmwr.mm7012a4.

Global Epidemiology of Tuberculosis and Progress Toward Achieving Global Targets - 2017.

MMWR Morb Mortal Wkly Rep. 2019 Mar 22;68(11):263-266. doi: 10.15585/mmwr.mm6811a3.

引用本文的文献

Miliary tuberculosis and central nervous system infection caused by hematogenous transmission from a primary subcutaneous tuberculous abscess: A case report.

Medicine (Baltimore). 2025 Sep 5;104(36):e44221. doi: 10.1097/MD.0000000000044221.

Isoniazid-rhodanine molecular hybrids: design, synthesis, antimycobacterial activity and computational validation.

RSC Adv. 2025 Sep 1;15(38):31272-31288. doi: 10.1039/d5ra03641k. eCollection 2025 Aug 29.

Risk factors and prevalence of latent tuberculosis infection in rheumatic patients: a meta-analysis.

BMC Infect Dis. 2025 Sep 2;25(1):1094. doi: 10.1186/s12879-025-11460-x.

Opportunistic use of artificial intelligence with X-ray imaging for diagnosis of HIV status in tuberculosis patients in Uganda and Tanzania.

PLOS Digit Health. 2025 Sep 2;4(9):e0000988. doi: 10.1371/journal.pdig.0000988. eCollection 2025 Sep.

Burden of tuberculosis in Eastern Africa region from 1990-2021: A systematic analysis for the Global Burden of Disease 2021 Study.

PLoS One. 2025 Sep 2;20(9):e0331035. doi: 10.1371/journal.pone.0331035. eCollection 2025.

Recent advancements in drug development for pulmonary tuberculosis.

Arch Microbiol. 2025 Aug 30;207(10):245. doi: 10.1007/s00203-025-04415-y.

Unlocking the secrets of glucose metabolism reprogramming: the role in pulmonary diseases.

Front Pharmacol. 2025 Aug 13;16:1551452. doi: 10.3389/fphar.2025.1551452. eCollection 2025.

Gut microbiota and tuberculosis.

Imeta. 2025 Jun 22;4(4):e70054. doi: 10.1002/imt2.70054. eCollection 2025 Aug.

Higher proportion of coagulative necrosis and PD-L1 immune cells in splenic tuberculosis.

Sci Rep. 2025 Aug 26;15(1):31348. doi: 10.1038/s41598-025-15754-7.

Whole-genome sequencing and machine learning reveal key drivers of delayed sputum conversion in rifampicin-resistant tuberculosis.

Front Cell Infect Microbiol. 2025 Aug 7;15:1641385. doi: 10.3389/fcimb.2025.1641385. eCollection 2025.